Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.19
+0.16 (1.77%)
May 22, 2026, 4:00 PM EDT - Market closed
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.55 billion as of May 22, 2026. Its market cap has increased by 107.24% in one year.
Market Cap
1.55B
Enterprise Value
1.17B
1-Year Change
107.24%
Ranking
Category
Stock Price
$9.19
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has increased from $1.53B to $1.55B, an increase of 1.05%. That is a compound annual growth rate of 0.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 1.55B | 84.75% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AtaiBeckley | 1.59B |
| AbCellera Biologics | 1.57B |
| Ardelyx | 1.57B |
| uniQure | 1.56B |
| Immunocore Holdings | 1.53B |
| Precigen | 1.53B |
| MBX Biosciences | 1.51B |
| Damora Therapeutics | 1.50B |